Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI

Jan 2, 2025 · Evercore ISI lowered the firm’s price target on Bausch + Lomb (BLCO) to $22 from $25 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for …

$22
OFF

Bausch + Lomb Price Target Lowered To $22 From $25 At Evercore ISI

2 weeks from now

Jan 2, 2025 · Evercore ISI lowered the firm’s price target on Bausch + Lomb (BLCO) to $22 from $25 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for …

nasdaq.com

$27.22
OFF

Evercore ISI Group Upgrades Bausch + Lomb (TSX:BLCO)

2 weeks from now

As of September 25, 2024, the average one-year price target for Bausch + Lomb is $27.22/share. The forecasts range from a low of $23.20 to a high of $35.47. The forecasts range from a low …

nasdaq.com

$19.00
OFF

Brokerages Set Bausch + Lomb Co. (NYSE:BLCO) Target Price At …

2 weeks from now

Dec 14, 2024 · Evercore ISI upgraded Bausch + Lomb from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $19.00 to $25.00 in a research note on …

etfdailynews.com

$19.00
OFF

Bausch + Lomb (NYSE:BLCO) Stock Rating Lowered By Citigroup

2 weeks from now

Dec 13, 2024 · Evercore ISI upgraded shares of Bausch + Lomb from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $19.00 to $25.00 in a …

defenseworld.net

51%
OFF

Evercore ISI Group Upgrades Bausch + Lomb (TSX:BLCO) - Fintel

2 weeks from now

Oct 16, 2024 · Fintel reports that on October 15, 2024, Evercore ISI Group upgraded their outlook for Bausch + Lomb from In-Line to Outperform. Analyst Price Forecast Suggests 4.51% …

fintel.io

$18
OFF

Evercore ISI Upgrades Bausch + Lomb To Outperform, Price Target …

2 weeks from now

-- Bausch + Lomb has an average outperform rating and a price target range of $18 to $25, according to analysts polled by Capital IQ. Price: 21.45, Change: +0.58, Percent Change: …

marketscreener.com

$22
OFF

BLCO News Today | Why Did Bausch + Lomb Stock Go Up Today?

2 weeks from now

Jan 8, 2025 · Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI. January 2, 2025 | markets.businessinsider.com ... Citigroup lowered shares of Bausch + Lomb from a …

marketbeat.com

$25
OFF

Bausch + Lomb Corporation: Target Price Consensus And Analysts ...

2 weeks from now

Dec 5, 2024 · Evolution of the Target Price: Bausch + Lomb Corporation. ... Evercore ISI Upgrades Bausch + Lomb to Outperform, Price Target is $25 Oct. 15: MT ... HC Wainwright …

marketscreener.com

$22
OFF

Bausch + Lomb Corporation Registered Shs Reg S Stock Price

2 weeks from now

Dec 22, 2024 · Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI Historical Prices for Bausch + Lomb Corporation Registered Shs Reg S Feb. 04 2021 Mar. 05 2021

businessinsider.com

$25
OFF

Bausch + Lomb Corporation: Target Price Consensus And Analysts ...

2 weeks from now

6 days ago · Evolution of the Target Price: Bausch + Lomb Corporation. ... 24-10-22: MT Evercore ISI Upgrades Bausch + Lomb to Outperform, Price Target is $25 24-10-15: MT Deutsche Bank …

marketscreener.com

$25
OFF

Bausch + Lomb Upgraded To Outperform From In Line At Evercore ISI

2 weeks from now

Evercore ISI analyst Vijay Kumar upgraded Bausch + Lomb to Outperform from In Line with a $25 price target Published first on TheFly – the ultimate source for real-time, market-moving …

tipranks.com

$20.14
OFF

Evercore ISI Group Upgrades Bausch + Lomb (BLCO) - MSN

2 weeks from now

As of September 24, 2024, the average one-year price target for Bausch + Lomb is $20.14/share. The forecasts range from a low of $17.17 to a high of $26.25. The forecasts range from a low …

msn.com

$22
OFF

BLCO Stock Quote Price And Forecast | CNN

2 weeks from now

Jan 02 6:46am ET Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI by TipRanks Dec 17 5:30am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: …

cnn.com

$19
OFF

BLCO - Bausch + Lomb Corp Stock Price And Quote - FINVIZ.com

2 weeks from now

Evercore ISI: In-line → Outperform: $19 → $25: Jul-10-24: Initiated: Raymond James: ... $25: May-31-22: Initiated: Guggenheim: Buy: $24: Show Previous Ratings ... Launch Second …

finviz.com

$20.14
OFF

Evercore ISI Group Upgrades Bausch + Lomb (BLCO) | Nasdaq

2 weeks from now

As of September 24, 2024, the average one-year price target for Bausch + Lomb is $20.14/share. The forecasts range from a low of $17.17 to a high of $26.25. The forecasts range from a low …

nasdaq.com

$26
OFF

Bausch + Lomb Price Target Raised To $26 From $23 At Wells Fargo

2 weeks from now

Oct 31, 2024 · Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI TipRanks 10d Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation …

businessinsider.com

$22
OFF

Bausch + Lomb Launches EnVista Aspire Monofocal, Toric …

2 weeks from now

2 days ago · Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI TipRanks 11d Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation …

businessinsider.com

$19
OFF

Bausch + Lomb Price Target Raised To $19 From $17 At Evercore ISI

2 weeks from now

Oct 2, 2024 · Evercore ISI raised the firm’s price target on Bausch + Lomb to $19 from $17 and keeps an In Line rating on the shares. In MedTech, utilization remains positive into Q3 and the …

yahoo.com

$12
OFF

BioCryst Price Target Raised To $12 From $10 At Evercore ISI

2 weeks from now

1 day ago · Evercore ISI raised the firm’s price target on BioCryst (BCRX) to $12 from $10 and keeps an Outperform rating on the shares. The company preannounced 2024 Orladeyo …

yahoo.com

FAQs about Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI Coupon?

Is Bausch & Lomb a good stock to buy?

Evercore ISI upgraded Bausch + Lomb from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $19.00 to $25.00 in a research note on Tuesday, October 15th. Needham & Company LLC reiterated a “hold” rating on shares of Bausch + Lomb in a research report on Thursday, October 31st. ...

What is the average price target for Bausch & Lomb?

As of September 24, 2024, the average one-year price target for Bausch + Lomb is $20.14/share. The forecasts range from a low of $17.17 to a high of $26.25. The average price target represents a decrease of 2.88% from its latest reported closing price of $20.74 / share. See our leaderboard of companies with the largest price target upside. ...

Should you buy Bausch & Lomb co (BLCO)?

Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) has been given an average recommendation of “Hold” by the thirteen analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company. ...

How much did Bausch & Lomb raise?

Bausch + Lomb (BLCO) raised $788 million in an initial public offering on Friday, May 6th 2022. The company issued 35,000,000 shares at $21.00-$24.00 per share. Who are Bausch + Lomb's major shareholders? ...

How do I receive news & ratings for Bausch & Lomb?

Receive News & Ratings for Bausch + Lomb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch + Lomb and related companies with MarketBeat.com's FREE daily email newsletter. This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. ...

Who sells Bausch & Lomb products?

The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc. Read More… ...